Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...

Summary Washington State wants to bring a Netflix model to Hepatitis C care on an RFP model winner-take-all basis. If cost is the major factor here, Gilead could win this contract. By itself, it ...

An HIV-prevention group alleges that Gilead postponed development on a safer drug so it could continue to gain monopoly profits from its older combination HIV drugs, including Truvada.

Bowing to criticism that it was exploiting the coronavirus pandemic, the drugmaker Gilead said on Wednesday that it would no longer seek orphan-drug status for remdesivir, an experimental drug ...

Besides Ascent-04, Gilead expects a readout by June from the phase 3 Ascent-03 trial pitting Trodelvy against chemo in first-line, PD-L1-negative metastatic TNBC.

Antimicrobial drug developer HOOKIPA Pharma (NASDAQ: HOOK) announced Thursday that Gilead Sciences (NASDAQ: GILD) has agreed to acquire some of its assets for a total consideration of up to $10M.

Gilead Sciences (NasdaqGS:GILD) has been the center of investor activism, facing several shareholder proposals, including the separation of the Chairman and CEO roles and developing a ...

In March 2019, at PrEP4All’s request, one of us (CM) analyzed the CDC’s patents and concluded that the patents appear valid, enforceable, and infringed by Gilead.

The lawsuit stems from a 2005 agreement between Gilead, Royalty Pharma and Emory University around emtricitabine, which is an important part of Gilead's multibillion-dollar HIV franchise.

One week after reporting deaths in blood cancer patients, the Big Biotech has paused enrollment of magrolimab solid tumor trials following the FDA's request for a partial clinical hold on the anti ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.

Gilead Sciences will stop considering individual emergency requests for its experimental coronavirus drug, except in certain circumstances, as it grapples with overwhelming demand.